GPhC should explain rise in premises fees, says PDA
The Pharmacistsâ€™ Defence Association (PDA) has urged the General Pharmaceutical Council (GPhC) to explain the rationale behind its proposed increased registration fee of Â£365 for pharmacy premises.
The regulator's official consultation on the premises fee hike closed at the end of March, during a time when many contractors have faced financial difficulties relating to the Covid-19 pandemic.
The fee for renewal and registration is set to go from Â£262 to Â£365, an increase the PDA said would give the GPhC Â£1.5 million in extra income.
The PDA said it supported â€œthe principle of a fee increaseâ€ but insisted the regulator act â€œin line with the Nolan Principle of Opennessâ€ and present â€œa full and comprehensive set of financial workings on how it has arrived at the figure of Â£365.â€
â€œThe GPhC should not raise fees until it can detail and demonstrate independently verifiable efficiency gains on an annual basis before coming back to registrants for any increase in fees,â€ the PDA said.
It also said the GPhC should not expect â€œyear on year increases in its income as a matter of rightâ€ and community pharmacy cannot support the â€œguarantee of a three-year fixed increase in fee income for the GPhC.â€
The PDA added: â€œThe GPhC must provide full working models on fees showing cost allocations according to registrant type.
â€œ(It) must provide data if it is to introduce variable fees to show how the variances would impact different groups of registrants (pharmacists/technicians/premises).â€
On accreditation MPharm courses, the PDA said fees must â€œproperly be charged to institutions and not allocated as a cost when determining pharmacist registration fees.â€
It also urged the GPhC to publish the equality impact analysis from the fees increase last year and in previous years.
When contacted by Independent Community Pharmacist, a GPhCÂ spokesperson said:Â â€œWe recognise that, at the current time, the first priority of pharmacy professionals and organisations is to focus on patient safety and dealing with the coronavirus outbreak.Â
â€œWe are carefully considering all responses to the consultation and will publish a summary of the responses, along with an explanation of the decision we have taken, in due course.â€
Update your knowledge on treating sore throat without antibiotics with this short, interactive module.
Explore our detailed case studies to help understand how to advise customers on different causes of pain.
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
Pharmacy technician awarded £7k after new manager banned breaks
A pharmacy technician with scoliosis who was prevented from taking breaks during her shift has been awarded almost Â£7,000.
1 Min Article
Pharmacies dispensing 4x usual volume in COVID-19 crisis
Pharmacists in Northern Ireland have warned the public they are under huge pressure due to the COVID-19 crisis.
2 Min Article
Sale of 44 Boots stores 'exciting opportunity for independents'
Boots has put 44 of its pharmacies in England and Wales up for sale.
1 Min Article
Treating acid reflux and heartburn in the pharmacy
Understand how omeprazole 20mg works to treat heartburn and acid reflux symptoms
4 Min Module
OTC Omeprazole tablets 20mg: an opportunity for pharmacy
This module highlights a new opportunity to treat heartburn and reflux in the pharmacy with Omeprazole 20mg, which is newly available for customers to purchase OTC.
22 Min Module